4 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
En Carta Diagnostics secures €1.5M to advance diagnostic kit platform for early Lyme disease detection

Groundbreaking patented molecular diagnostic kit poised to provide game-changing autonomous Lyme detection in minutes

27-May-2024

En Carta Diagnostics, a deeptech start-up developing rapid Point-of-Care (POC) molecular diagnostics kits, announces €1.5M ($1.63M) in pre-seed funding. This investment will enable En Carta to make a substantial leap forward in achieving preclinical data on a prototype diagnostic kit for its ...

more

image description
Customized coating designs against resistant bacteria and viruses, including SARS-CoV-2

Spartha Medical receives €2.4M in financing from European Innovation Council

01-Feb-2022

Spartha Medical, a French medtech start-up specialized in developing multifunctional antimicrobial, antiviral and anti-inflammatory coatings, announces it has received €2.4M ($2.75M) in grants and an additional undisclosed equity financing from the European Innovation Council (EIC) Fund. Spartha ...

more

image description
Vésale Bioscience named most innovative start-up in life sciences in Europe

The Belgian start-up is developing an effective and reproducible phage therapy approach that offers a personalized solution to the major issue of AntiMicrobial Resistance

13-Dec-2021

Vésale Bioscience, a biotech company specializing in phage therapy, with a particular focus on research into alternative solutions to antibiotics and the development of treatments for multidrug-resistant infections, announced that it has been awarded the prize for most innovative start-up in life ...

more

image description
German-based startup attracts venture funding to address ‘Agitation/Aggression’ in Alzheimer’s disease

Exciva raises €9 million in Series A round

02-Nov-2021

Exciva GmbH, a clinical biotech startup developing a novel therapeutic compound for treating agitation/aggression in Alzheimer’s disease, announces the closing of a Series A financing of €9 million ($10M) led by Andera Partners. LBBW Venture Capital and Cure8 also participated in the round. This ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE